Aspirin may prevent colon cancer
This article was translated by an automatic translation system, and was therefore not reviewed by people.
People genetically susceptible to having colon cancer can reduce the chances of developing the disease with a single dose of aspirin. A statement made Monday by British scientists during a meeting in Berlin, may lead to new treatments against evil.
For the study, researchers followed 1071 patients with Lynch syndrome, a hereditary condition that predisposes people to various types of cancer, especially colon cancer. Over four years, about half of the participants received two aspirin per day (the total, 600 milligrams), while the rest received placebo.
At the end of the experiment, only 6 people developed colon cancer in the group receiving aspirin, while 16 showed disease in the placebo group. "We were very pleased," said the lead researcher, John Burn, Newcastle University, according to the Associated Press.
Despite the benefits, aspirin can have side effects such as bleeding and irritation of the stomach. In the study, 11 patients in the group receiving aspirin had stomach bleeding or ulcers, compared with 9 in the placebo group.
Source: Veja.com
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.
